Evidence map›Paper›PMID 40079401›Full record

ArticleThe journal of pathology. Clinical research2025

Do explainable AI (XAI) methods improve the acceptance of AI in clinical practice? An evaluation of XAI methods on Gleason grading.

Robin Manz, Jonas Bäcker, Samantha Cramer, Philip Meyer, Dominik Müller, Anna Muzalyova, Lukas Rentschler, Christoph Wengenmayr, Ludwig Christian Hinske, Ralf Huss and 2 more

Abstract readEvaluation Study
In one paragraph

Article in The journal of pathology. Clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robin ManzDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.ORCID 0009-0001-5339-6091
Jonas BäckerDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.
Samantha CramerDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.
Philip MeyerDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.
Dominik MüllerDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0003-0838-9885
Anna MuzalyovaDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0003-4441-8006
Lukas RentschlerInstitute for Pathology and Molecular Diagnostics, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0001-7260-0177
Christoph WengenmayrDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.
Ludwig Christian HinskeDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.
Ralf HussInstitute for Pathology and Molecular Diagnostics, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0002-6447-9300
Johannes RafflerDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0003-2495-4020
Iñaki Soto-ReyDigital Medicine, University Hospital of Augsburg, Augsburg, Germany.ORCID 0000-0003-3061-5818

Funding

Augsburg University, Intramural Funding
6 · The paper itself

Abstract

This work aimed to evaluate both the usefulness and user acceptance of five gradient-based explainable artificial intelligence (XAI) methods in the use case of a prostate carcinoma clinical decision support system environment. In addition, we aimed to determine whether XAI helps to increase the acceptance of artificial intelligence (AI) and recommend a particular method for this use case. The evaluation was conducted on a tool developed in-house with different visualization approaches to the AI-generated Gleason grade and the corresponding XAI explanations on top of the original slide. The study was a heuristic evaluation of five XAI methods. The participants were 15 pathologists from the University Hospital of Augsburg with a wide range of experience in Gleason grading and AI. The evaluation consisted of a user information form, short questionnaires on each XAI method, a ranking of the methods, and a general questionnaire to evaluate the performance and usefulness of the AI. There were significant differences between the ratings of the methods, with Grad-CAM++ performing best. Both AI decision support and XAI explanations were seen as helpful by the majority of participants. In conclusion, our pilot study suggests that the evaluated XAI methods can indeed improve the usefulness and acceptance of AI. The results obtained are a good indicator, but further studies involving larger sample sizes are warranted to draw more definitive conclusions.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalNeoplasm GradingProstatic NeoplasmsHumansMalePilot ProjectsSurveys and Questionnairesartificial intelligenceclinical decision supportevaluationexplainable artificial intelligenceGleason scorepathologyprostate carcinoma

Identifiers

PMID40079401
PMCPMC11904816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.